Abstract
References
Articles referenced by this article (115)
The subcellular localization of acetyl-CoA carboxylase 2.
Proc Natl Acad Sci U S A, (4):1444-1449 2000
MED: 10677481
Metabolism and action of amino acid analog anti-cancer agents.
Pharmacol Ther, (2):243-271 1990
MED: 2108451
Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer.
Oncoimmunology, (8):e1200771 2016
MED: 27622069
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin.
Biochem Pharmacol, 113787 2019
MED: 31884044
LXR signaling couples sterol metabolism to proliferation in the acquired immune response.
Cell, (1):97-111 2008
MED: 18614014
De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.
Nat Med, (11):1327-1333 2014
MED: 25282359
Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport.
Mol Cancer Ther, (12):2805-2816 2014
MED: 25281618
Effector T cells require fatty acid metabolism during murine graft-versus-host disease.
Blood, (18):3230-3237 2013
MED: 24046012
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes.
Cancer Res, (11):2746-2756 2012
MED: 22593198
Show 10 more references (10 of 115)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/160622886
Article citations
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.
Signal Transduct Target Ther, 9(1):270, 11 Oct 2024
Cited by: 0 articles | PMID: 39389953 | PMCID: PMC11467208
Review Free full text in Europe PMC
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapy.
Biomaterials, 312:122750, 08 Aug 2024
Cited by: 0 articles | PMID: 39126779
A Bibliometric Analysis of Metabolic Reprogramming in the Tumor Microenvironment From 2003 to 2022.
Cancer Rep (Hoboken), 7(8):e2146, 01 Aug 2024
Cited by: 0 articles | PMID: 39158178 | PMCID: PMC11331499
Review Free full text in Europe PMC
The role of RNA methylation in tumor immunity and its potential in immunotherapy.
Mol Cancer, 23(1):130, 20 Jun 2024
Cited by: 4 articles | PMID: 38902779 | PMCID: PMC11188252
Review Free full text in Europe PMC
A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis.
Front Immunol, 15:1331841, 02 Feb 2024
Cited by: 3 articles | PMID: 38370403 | PMCID: PMC10869553
Go to all (41) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy.
Front Immunol, 9:353, 23 Feb 2018
Cited by: 112 articles | PMID: 29527212 | PMCID: PMC5829092
Review Free full text in Europe PMC
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
Trends Cancer, 3(8):583-592, 14 Jul 2017
Cited by: 101 articles | PMID: 28780935
Review
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Int J Mol Sci, 22(11):5736, 27 May 2021
Cited by: 26 articles | PMID: 34072260 | PMCID: PMC8199456
Review Free full text in Europe PMC
Metabolic reprogramming in tumor immune microenvironment: Impact on immune cell function and therapeutic implications.
Cancer Lett, 597:217076, 19 Jun 2024
Cited by: 1 article | PMID: 38906524
Review